logo-loader
viewEquals Group Plc

Equals Group raises £14.3mln through placing and open offer

The company said previously that it would use the proceeds to fund the development of its corporate products

Equals Group Plc - Equals Group raises £14.3mln through placing and open offer

Equals Group Plc (LON:EQLS) has raised a total of £14.3mln through a placing and an open offer.

The e-banking an international payments firm said at the close of acceptance for the open offer at 11am on 3 September it had received acceptances for 246,173 shares at the placing price of 110p.

READ: Equals Group to speed up corporate products development after funding round

The close of the open offer follows the completion of a £14mln share placing on 20 August, when the company placed around 12.7mln new shares.

When it announced the placing and offer on 16 August, Equals said it would use the funds to accelerate plans for corporate products, as well as providing opportunities for bolt-on acquisitions.

Quick facts: Equals Group Plc

Price: 77.85 GBX

AIM:EQLS
Market: AIM
Market Cap: £139.04 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Equals Group Plc named herein, including the promotion by the Company of Equals Group Plc in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Equals Group PLC raises £16mln for acquisitions

Top stories from the Proactive UK newsroom. E payments group Equals (LON:EQLS) is to raise £16mln though a placing and open offer to give it some firepower to make acquisitions and accelerate the development of its corporate product.  Healthcare marketing group Cello Health (LON:CLL)...

on 16/8/19

2 min read